EURO-MED LABORATORIES PHIL., INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.73 PHP | 0.00% |
|
-1.35% | -2.67% |
| Sales 2022 | 4.22B 73.01M | Sales 2023 | 5.26B 90.99M | Capitalization | 3.08B 53.31M |
|---|---|---|---|---|---|
| Net income 2022 | 200M 3.46M | Net income 2023 | 290M 5.01M | EV / Sales 2022 | 1.53 x |
| Net Debt 2022 | 2.87B 49.68M | Net Debt 2023 | 2.96B 51.09M | EV / Sales 2023 | 1.15 x |
| P/E ratio 2022 |
17.9
x | P/E ratio 2023 |
10.7
x | Employees | 1,604 |
| Yield 2022 |
4.02% | Yield 2023 |
-
| Free-Float | 11.69% |
More Fundamentals
* Assessed data
More news
| 1 week | -1.35% | ||
| Current month | -7.59% | ||
| 1 month | -1.35% | ||
| 3 months | -6.41% | ||
| 6 months | -12.05% | ||
| Current year | -2.67% |
1 week
0.73
0.79
1 month
0.730.79
Current year
0.710.80
1 year
0.700.88
3 years
0.702.15
5 years
0.704.49
10 years
0.704.49
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 63 | 89-12-31 | |
Jose Emiterio
CMP | Compliance Officer | 73 | 06-12-31 |
| Director/Board Member | 69 | 89-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Johnny Yap
BRD | Director/Board Member | 52 | 92-12-31 |
Basilio Yap
BRD | Director/Board Member | 75 | 14-06-17 |
William Padolina
CHM | Chairman | 77 | 89-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 0.73 | 0.00% | 0 |
| 24-04-24 | 0.73 | -7.59% | 6,000 |
| 24-04-23 | 0.79 | +6.76% | 23,000 |
| 24-04-22 | 0.74 | 0.00% | 33,000 |
| 24-04-19 | 0.74 | 0.00% | 15,000 |
End-of-day quote Philippines S.E., April 24, 2024
More quotes
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.67% | 51.94M | |
| +19.23% | 22.25B | |
| +13.49% | 14.39B | |
| +12.83% | 13.55B | |
| +38.02% | 11.27B | |
| -9.70% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.01B | |
| -5.36% | 4.51B |
- Stock Market
- Equities
- EURO Stock
